Reducing Fraud and Lowering Barriers to the Production of Drugs in Shortage by Outsourcing Facilities

The Food and Drug Administration (FDA) is seeking to reduce fraud and lower barriers to the production of drugs in shortage by outsourcing facilities. The goal of this grant is to better understand the landscape of drug shortage products, including those vulnerable to health fraud, and identify opportunities for outsourcing facilities to meet drug shortage needs. Funding would also support outsourcing facilities' research and development of products that mitigate persistent drug shortages to increase the supply of critical medications and stabilize the drug supply chain to prevent health fraud. The eligible applicants include higher education institutions, public/state controlled institutions of higher education, private institutions of higher education, nonprofits other than institutions of higher education, for-profit organizations, small businesses, and local governments. The estimated funding for this grant is $3,000,000, and the award ceiling is also $3,000,000. • The grant aims to strengthen the supply chain by increasing the supply of critical medications. • The grant seeks to prevent health fraud by stabilizing the drug supply chain. • The eligible applicants include a wide range of organizations, including higher education institutions, nonprofits, and for-profit organizations. • The estimated funding for this grant is $3,000,000. • The award ceiling is also $3,000,000.